05 / Evidence and accountability
Sources are the start.
Not the conclusion.
A source can be reliable about one thing and insufficient for another. This register explains the distinction. Updated 21 November 2026.
- FACT film listing
- Exhibitor listing: title, directors, 174-minute runtime and Liverpool screenings. Reviewed listing text. Marketing copy does not authenticate every scene or allegation.
- Film at Lincoln Center festival listing
- Institutional programme: directors, year, runtime and Billy Evans’s identification as Holmes’s romantic partner. Reviewed programme text. Not a complete production-credit or background audit.
- Rolling Stone interview with Fielder, Oppenheim and Seyfried
- Participant account of production and recreation. Selected passages inspected, not a full independent audit. Their recollections and explanations remain attributable accounts; the published conversation is edited.
- Court trial Exhibit 3696
- Original presentation. Pages 3 and 8 visually inspected in earlier research; other inspection was partial/OCR. Establishes wording, not its scientific truth or delivery to every investor. Full contextual audit pending.
- SEC 2018 complaint
- Regulator’s allegations. Paragraphs 48–51 are an investor-materials research pointer. Not a verdict on every assertion. Earlier research is being carried forward, not represented as a fresh complete reading.
- DOJ account of Holmes’s January 2022 verdict
- Official prosecution account; verdict passage inspected, including acquittals and unresolved counts. Not the full judgment or a current appeal-status report.
- DOJ account of Balwani’s role and verdict
- Official role/verdict reference located through search; full-page review pending. Do not extrapolate his findings to other people.
- JCI comparison of low-volume laboratory testing
- Peer-reviewed study: abstract and selected methods passages inspected. 60 healthy adults and 22 tests. Study scope is not every assay, patient population or proprietary instrument. Full methods, limitations and conflict-of-interest review remains necessary.
- Theranos’s 2016 technology announcement
- Company statement, retained from earlier research. Evidence of the company’s presentation, not independent performance validation.
- Patent US8283155B2
- Patent-record starting point. Full claims, ownership and implementation audit unfinished. No clinical inference follows merely from grant or publication.
How conclusions should be labelled
Use document wording, participant account, legal allegation, reported verdict, scientific study, interpretation or open question. Explain the limitation at the claim, not only in a disclaimer elsewhere. A source count is not a truth score.
Corrections and contributors
Open a source-backed issue. Give the page, exact statement, proposed correction and supporting passage. Contributions are proposals until reviewed. Preserve who submitted, who reviewed, what changed and the exact revision. Never post confidential or sensitive personal material.
The graph currently uses a small curated set of relationships; it does not represent a complete evidence database. Structured imports, individual review receipts and a published correction ledger remain implementation work.